Related Experiment Video
Updated: Jun 1, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Australian community pharmacists' practice in complementary medicines: a structural equation modeling approach
Tipaporn Kanjanarach1, Ines Krass, Robert G Cumming
1Khon Kaen University, Khon Kaen, Thailand. otipkan@kku.ac.th
Patient Education and Counseling
|May 31, 2011
Summary
Pharmacists accepting responsibility for counseling on complementary medicines (CMs) strongly influences their evaluation of CM appropriateness and sales decisions. Encouraging this acceptance is key for safe CM use.
Area of Science:
- Pharmacy practice
- Complementary medicine research
- Health behavior
Background:
- Community pharmacists play a role in complementary medicine (CM) use.
- Understanding factors influencing pharmacist practice regarding CMs is crucial for patient safety.
Purpose of the Study:
- To test a model of factors influencing pharmacists' practice concerning complementary medicines (CMs).
- To examine the relationship between pharmacists' perceptions of responsibility and their practices in evaluating and selling CMs.
Main Methods:
- A survey of 212 community pharmacists in New South Wales using self-administered questionnaires.
- Structural equation modeling (AMOS v6.0) was employed to analyze data on CM evaluation and sales decisions.
Main Results:
- Pharmacists' perceived responsibility for safe CM use predicted comprehensive appropriateness evaluations (P=0.002).
- Increased evaluation comprehensiveness led to reduced sales of inappropriate CMs (P=0.021).
- Pharmacist knowledge, attitudes, income concerns, and characteristics did not significantly impact practice.
Conclusions:
- Pharmacists' acceptance of counseling responsibility for CMs is the primary predictor of evaluation thoroughness and sales decisions.
- Pharmacists should be supported in recognizing and embracing their role in ensuring safe and effective CM use.
Related Concept Videos
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...